1415 W. Diehl Road
About physIQPhysIQ is a company dedicated to enabling proactive care delivery models through its Personalized Physiology Analytics (PPA) and highly scalable cloud-based platform. The FDA 510k-cleared data analytics platform is designed to process multiple vital signs from wearable sensors to create a personalized dynamic baseline for each individual. By mapping vital sign relationships this way, physIQ’s analytics detect subtle deviations that may be a precursor to disease exacerbation or change in health and warrant clinical attention. With applications in both healthcare delivery and clinical trial support, physIQ is transforming continuous physiological data into insight for providers, health systems, payers, and pharmaceutical and medical device companies.
Founder and CEO: Gary Conkright
Founder and CTO: Matt Pipke
CMO: Stephen Ondra
CSO: Stephan Wegerich
Please click here for physIQ job opportunities.
5 articles with physIQ
PhysIQ Inc. Receives FDA Clearance of Continuous Ambulatory Respiration Rate Algorithm Enabling Artificial Intelligence-based Analytics for Biopharma Companies and Payers
FDA 510(k) cleared Respiration Rate analytic adds to physIQ’s growing portfolio of FDA 510(k) algorithms
- Omron HeartGuide®, the first wearable blood pressure device, will integrate with physIQ’s pinpointIQ® analytics platform to indicate a potential health risk - This combined solution is being deployed to help manage recently-discharged, at-risk patients - The goal is to provide clinicians with physiological insight to proactively address potential clinical deterioration
FDA 510(k) cleared Atrial Fibrillation (AFib) detection analytic adds to physIQ’s portfolio of FDA 510(k) algorithms
Netherlands-based Haga Teaching Hospital partners with physIQ and VitalConnect to continuously monitor cancer patients during treatment
Cancer patients are equipped with wearable biosensors for monitoring before, during and after cancer treatment